QUALITY AND TRANSPARENCY
News

Deborah A. Zarin is featured in STAT’s Pharmalot’s article about FDA penalties for clinical trial sponsors that don’t share data

Deborah A. Zarin is featured in STAT’s Pharmalot’s “FDA finalizes penalties for clinical trial sponsors that don’t share data, but critics say they fall short.”

Read article >